Melinda Iliopoulos

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Top Venues

Journal for immunotherapy of cancer

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang, Sarah J McArthur, Lisa M Ebert, Alexander J Davenport, Raelene Endersby, Jordan R Hansford, Katharine J Drummond, Ryan S Cross, Misty R Jenkins
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for immunotherapy of cancer 12 (8) (2024)
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & translational immunology 12 (3) (2023)
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes-Parry, Pete Smith, Melissa J Call, Ryan S Cross, Misty R Jenkins
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & translational immunology 12 (3) (2023)